Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries NanoVibronix, Inc. - Common Stock (NQ: NAOV ) 0.6100 -0.0014 (-0.23%) Streaming Delayed Price Updated: 2:37 PM EST, Dec 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 34,386 Open 0.6120 Bid (Size) 0.5800 (5) Ask (Size) 0.6100 (2) Prev. Close 0.6114 Today's Range 0.5700 - 0.6250 52wk Range 0.4550 - 1.520 Shares Outstanding 3,752,354 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News NanoVibronix Secures $12 Million Minimum Purchase Commitment for PainShield with Extension of Distribution Agreement December 11, 2024 From NanoVibronix, Inc. Via Business Wire NanoVibronix Provides Business Update November 12, 2024 From NanoVibronix, Inc. Via Business Wire Performance YTD -46.96% -46.96% 1 Month -13.96% -13.96% 3 Month -0.34% -0.34% 6 Month -14.42% -14.42% 1 Year -45.54% -45.54% More News Read More NanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in Germany October 09, 2024 From NanoVibronix, Inc. Via Business Wire NAOV Stock Earnings: NanoVibronix Reported Results for Q2 2024 August 15, 2024 Via InvestorPlace NAOV Stock Earnings: NanoVibronix Reported Results for Q1 2024 May 15, 2024 Via InvestorPlace NAOV Stock Earnings: NanoVibronix Reported Results for Q4 2023 April 10, 2024 Via InvestorPlace NanoVibronix Signs Letter of Intent with Potential New Distributor September 23, 2024 From NanoVibronix, Inc. Via Business Wire NanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to Stockholders August 21, 2024 From NanoVibronix, Inc. Via Business Wire NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan May 22, 2024 From NanoVibronix, Inc. Via Business Wire NanoVibronix Issues Letter to Stockholders May 16, 2024 From NanoVibronix, Inc. Via Business Wire NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield May 14, 2024 From NanoVibronix, Inc. Via Business Wire 12 Health Care Stocks Moving In Friday's Pre-Market Session May 03, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday May 03, 2024 Via InvestorPlace Why Apple Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket May 03, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session May 01, 2024 Via Benzinga NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs’ FSS Contract Award May 01, 2024 From NanoVibronix, Inc. Via Business Wire NanoVibronix Issues Letter to Stockholders April 09, 2024 From NanoVibronix, Inc. Via Business Wire NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield March 28, 2024 From NanoVibronix, Inc. Via Business Wire 12 Health Care Stocks Moving In Monday's After-Market Session January 29, 2024 Via Benzinga NanoVibronix Featured in Your Bladder Health Magazine December 06, 2023 From NanoVibronix, Inc. Via Business Wire NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity December 04, 2023 From NanoVibronix, Inc. Via Business Wire NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan November 28, 2023 From NanoVibronix, Inc. Via Business Wire NanoVibronix Regains Nasdaq Compliance November 21, 2023 From NanoVibronix, Inc. Via Business Wire 12 Health Care Stocks Moving In Monday's After-Market Session November 20, 2023 Via Benzinga NanoVibronix Issues Letter to Shareholders November 14, 2023 From NanoVibronix, Inc. Via Business Wire Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
